Richard Lafayette
Overview
Explore the profile of Richard Lafayette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamal F, Kim J, Lafayette R
Semin Nephrol
. 2025 Mar;
:151572.
PMID: 40087126
IgA nephropathy (IgAN) is the most prevalent primary glomerular disease and has been recognized to carry a poor prognosis. It is therefore critical to identify the patients that will progress...
2.
Zhang H, Lafayette R, Wang B, Ying L, Zhu Z, Stone A, et al.
Kidney360
. 2024 Dec;
5(12):1881-1892.
PMID: 39724565
Background: IgA nephropathy (IgAN), an immune-mediated kidney disease, is particularly prevalent among individuals of East Asian ancestry. Nefecon is a novel, oral, targeted-release budesonide formulation designed to inhibit galactose-deficient IgA1...
3.
Barratt J, Barbour S, Brenner R, Cooper K, Wei X, Eren N, et al.
J Am Soc Nephrol
. 2024 Oct;
PMID: 39462308
No abstract available.
4.
Lafayette R, Tumlin J, Fenoglio R, Kaufeld J, Perez Valdivia M, Wu M, et al.
J Am Soc Nephrol
. 2024 Oct;
PMID: 39455063
No abstract available.
5.
Tang S, Wei C, Aldworth C, George A, Kattlun J, Tomas G, et al.
Kidney360
. 2024 Oct;
PMID: 39437219
Background: Immunoglobulin A nephropathy (IgAN) is a chronic, progressive kidney disease in which proteinuria, reduced estimated glomerular filtration rate (eGFR), pain and fatigue are common. How symptoms interact and impact...
6.
Vorperian S, DeFelice B, Buonomo J, Chinchinian H, Gray I, Yan J, et al.
Clin Chem
. 2024 Oct;
70(11):1344-1354.
PMID: 39383112
Background: Early detection of the cell type changes underlying several genitourinary tract diseases largely remains an unmet clinical need, where existing assays, if available, lack the cellular resolution afforded by...
7.
Lafayette R
Nephrology (Carlton)
. 2024 Sep;
29 Suppl 2:44-46.
PMID: 39327741
The role of complement in the pathogenesis of IgA nephropathy has been heavily explored over the past 50 years. This has led to the general acceptance that complement plays an...
8.
Cheung C, Barratt J, Lafayette R, Liew A, Suzuki Y, Tesar V, et al.
Kidney Int
. 2024 Aug;
106(5):806-818.
PMID: 39182759
A proliferation-inducing ligand (APRIL) is a key member of the tumor necrosis factor superfamily of cytokines and plays a central role in B-cell survival, proliferation, and Ig class switching. Recently,...
9.
Yu S, Deoliveira M, Chung M, Lafayette R
Adv Kidney Dis Health
. 2024 Jul;
31(3):216-222.
PMID: 39004461
Membranoproliferative glomerulonephritis (MPGN) is no longer a disease but a pattern of injury in various diseases. Characterized by electron-dense deposits, mesangial proliferation, and duplication of the glomerular basement membrane, MPGN...
10.
Lafayette R, Kristensen J, Stone A, Barratt J
Lancet
. 2024 Jun;
403(10446):2786.
PMID: 38944527
No abstract available.